VERTEX PHARMACEUTICALS INC / MA Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for January 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 30 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 91.05 | 15,085 | 1,373,489 | 19,397 | |
Jan 30 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 170.00 | 15,085 | 2,564,450 | 39,163 | 54.2 K to 39.2 K (-27.81 %) |
Jan 30 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 91.05 | 15,085 | 1,373,489 | 54,248 | 39.2 K to 54.2 K (+38.52 %) |
Jan 26 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 86.52 | 4,659 | 403,097 | 20,193 | |
Jan 26 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 91.05 | 4,310 | 392,426 | 19,397 | |
Jan 26 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 169.00 | 8,969 | 1,515,761 | 41,952 | 50.9 K to 42 K (-17.61 %) |
Jan 26 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 86.52 | 4,659 | 403,097 | 50,921 | 46.3 K to 50.9 K (+10.07 %) |
Jan 26 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 91.05 | 4,310 | 392,426 | 46,262 | 42 K to 46.3 K (+10.27 %) |
Jan 25 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 86.52 | 5,824 | 503,892 | 25,241 | |
Jan 25 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 165.00 | 5,824 | 960,960 | 39,163 | 45 K to 39.2 K (-12.95 %) |
Jan 25 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 86.52 | 5,824 | 503,892 | 44,987 | 39.2 K to 45 K (+14.87 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 59.55 | 10,000 | 595,500 | 0 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 59.55 | 10,000 | 595,500 | 10,000 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 165.00 | 10,000 | 1,650,000 | 6,217 | 16.2 K to 6.2 K (-61.66 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 59.55 | 10,000 | 595,500 | 16,217 | 6.2 K to 16.2 K (+160.85 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 160.00 | 10,000 | 1,600,000 | 6,217 | 16.2 K to 6.2 K (-61.66 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 59.55 | 10,000 | 595,500 | 16,217 | 6.2 K to 16.2 K (+160.85 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 90.29 | 1,719 | 155,209 | 8,594 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 91.05 | 1,289 | 117,363 | 11,602 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 86.52 | 2,427 | 209,984 | 10,517 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 166.05 | 3,008 | 499,478 | 16,634 | 19.6 K to 16.6 K (-15.31 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 90.29 | 1,719 | 155,209 | 19,642 | 17.9 K to 19.6 K (+9.59 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 91.05 | 1,289 | 117,363 | 17,923 | 16.6 K to 17.9 K (+7.75 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 161.52 | 2,427 | 392,009 | 16,634 | 19.1 K to 16.6 K (-12.73 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 86.52 | 2,427 | 209,984 | 19,061 | 16.6 K to 19.1 K (+14.59 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 91.05 | 1,796 | 163,526 | 16,164 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 160.00 | 1,796 | 287,360 | 49,761 | 51.6 K to 49.8 K (-3.48 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 91.05 | 1,796 | 163,526 | 51,557 | 49.8 K to 51.6 K (+3.61 %) |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 83.36 | 13,750 | 1,146,200 | 0 | |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 83.36 | 13,750 | 1,146,200 | 13,750 | |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 77.31 | 18,672 | 1,443,532 | 2,578 | |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 160.00 | 13,750 | 2,200,000 | 39,163 | 52.9 K to 39.2 K (-25.99 %) |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 83.36 | 13,750 | 1,146,200 | 52,913 | 39.2 K to 52.9 K (+35.11 %) |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 159.35 | 700 | 111,545 | 39,163 | 39.9 K to 39.2 K (-1.76 %) |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 158.59 | 13,312 | 2,111,150 | 39,863 | 53.2 K to 39.9 K (-25.03 %) |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 157.67 | 18,410 | 2,902,705 | 53,175 | 71.6 K to 53.2 K (-25.72 %) |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 83.36 | 13,750 | 1,146,200 | 71,585 | 57.8 K to 71.6 K (+23.77 %) |
Jan 23 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 77.31 | 18,672 | 1,443,532 | 57,835 | 39.2 K to 57.8 K (+47.68 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 159.41 | 3,955 | 630,467 | 49,761 | 53.7 K to 49.8 K (-7.36 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 158.82 | 10,585 | 1,681,110 | 53,716 | 64.3 K to 53.7 K (-16.46 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 157.71 | 6,130 | 966,762 | 64,301 | 70.4 K to 64.3 K (-8.70 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 156.63 | 11,767 | 1,843,065 | 70,431 | 82.2 K to 70.4 K (-14.32 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 155.77 | 23,813 | 3,709,351 | 82,198 | 106 K to 82.2 K (-22.46 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 45.11 | 55,313 | 2,495,169 | 0 | |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 48.74 | 44,250 | 2,156,745 | 0 | |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 159.39 | 7,995 | 1,274,323 | 132,497 | 140.5 K to 132.5 K (-5.69 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 158.79 | 17,918 | 2,845,199 | 140,492 | 158.4 K to 140.5 K (-11.31 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 157.67 | 11,471 | 1,808,633 | 158,410 | 169.9 K to 158.4 K (-6.75 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 156.62 | 19,808 | 3,102,329 | 169,881 | 189.7 K to 169.9 K (-10.44 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 155.77 | 42,371 | 6,600,131 | 189,689 | 232.1 K to 189.7 K (-18.26 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 45.11 | 55,313 | 2,495,169 | 232,060 | 176.7 K to 232.1 K (+31.30 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 48.74 | 44,250 | 2,156,745 | 176,747 | 132.5 K to 176.7 K (+33.40 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 0.00 | 262 | 0 | 6,119 | |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 96.87 | 2,125 | 205,849 | 4,250 | |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 159.29 | 500 | 79,645 | 40,888 | 41.4 K to 40.9 K (-1.21 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 158.11 | 400 | 63,244 | 41,388 | 41.8 K to 41.4 K (-0.96 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 157.02 | 400 | 62,808 | 41,788 | 42.2 K to 41.8 K (-0.95 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 155.80 | 825 | 128,535 | 42,188 | 43 K to 42.2 K (-1.92 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | M | 96.87 | 2,125 | 205,849 | 43,013 | 45.1 K to 43 K (-4.71 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 96.87 | 1,719 | 166,520 | 3,438 | |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 159.04 | 300 | 47,712 | 54,424 | 54.7 K to 54.4 K (-0.55 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 157.54 | 900 | 141,786 | 54,724 | 55.6 K to 54.7 K (-1.62 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 155.80 | 519 | 80,860 | 55,624 | 56.1 K to 55.6 K (-0.92 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 96.87 | 1,719 | 166,520 | 56,143 | 54.4 K to 56.1 K (+3.16 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 96.87 | 2,125 | 205,849 | 4,250 | |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 158.28 | 2,125 | 336,345 | 41,952 | 44.1 K to 42 K (-4.82 %) |
Jan 17 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 96.87 | 2,125 | 205,849 | 44,077 | 42 K to 44.1 K (+5.07 %) |
Jan 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 90.29 | 2,125 | 191,866 | 21,250 | |
Jan 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 157.16 | 2,125 | 333,965 | 28,943 | 31.1 K to 28.9 K (-6.84 %) |
Jan 16 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 90.29 | 2,125 | 191,866 | 31,068 | 28.9 K to 31.1 K (+7.34 %) |
Jan 12 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 109.14 | 4,250 | 463,845 | 21,250 | |
Jan 12 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 159.00 | 4,250 | 675,750 | 41,952 | 46.2 K to 42 K (-9.20 %) |
Jan 12 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 109.14 | 4,250 | 463,845 | 46,202 | 42 K to 46.2 K (+10.13 %) |
Jan 09 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Option Exercise | M | 126.68 | 10,753 | 1,362,190 | 19,247 | |
Jan 09 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Sell | S | 156.00 | 10,753 | 1,677,468 | 3,953 | 14.7 K to 4 K (-73.12 %) |
Jan 09 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Buy | M | 126.68 | 10,753 | 1,362,190 | 14,706 | 4 K to 14.7 K (+272.02 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 3,438 | 252,727 | 0 | |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 152.80 | 863 | 131,866 | 54,424 | 55.3 K to 54.4 K (-1.56 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 152.06 | 1,600 | 243,296 | 55,287 | 56.9 K to 55.3 K (-2.81 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 150.87 | 675 | 101,837 | 56,887 | 57.6 K to 56.9 K (-1.17 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 149.65 | 300 | 44,895 | 57,562 | 57.9 K to 57.6 K (-0.52 %) |
Jan 03 2018 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 3,438 | 252,727 | 57,862 | 54.4 K to 57.9 K (+6.32 %) |